• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BP8
Click for more information
0.00% 0.1¢

BPH GLOBAL LTD - News & Media

Market Cap $1.954M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

BPH Global Ltd is a plant-focused biotechnology company. The Company is focused on... BPH Global Ltd is a plant-focused biotechnology company. The Company is focused on producing foods and products that deliver Traditional Chinese Medicine-based health outcomes. It focuses on the research and development, production and commercialization of plant-based products, including seaweed and sea plants to produce sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients (including cannabidiol (CBD) extracted from Hemp) for utilization in the food, nutrition, healthcare, cosmetics, and personal care industries. Its principal business focus is on Singapore, Australia, Southeast Asia, and Chinese markets. The Company produces its products through various plants, which include Caulerpa lentillifera, Dendrobium officinale, Resina and Cannabis sativa. It is also into the sales and distribution of bird's nest products in China. Its subsidiaries include Stemcell United Pte Ltd, Stemcell Essential Pte Ltd, and SCU Southeast Asia Sdn Bhd, SCU (HK) Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No News & Media currently available.

(20min delay)
Last
0.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $1.954M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
Last
0.1¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
0.1¢ 0.1¢ 0.1¢ 1200000
Last updated 10.39am 10/05/2024 ?
BP8 (ASX) Chart

Top Stories

Raiden opens door to private Mallina in win-win Arrow Gold divestment

Raiden Resources has announced its execution of a farm-in deal on-site Raiden's non-core asset, the Arrow gold project.
Recce breathes better on positive lung infection drug pilot test results Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Tamboran is listing on the NYSE, and Wall Street is paying attention If you needed evidence that Tamboran Resources is bullish on the NT's Beetaloo Basin, look no further than its decision to list on the NYSE.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
Gold grading beyond 65g/t at Hillgrove gets Larvotto shares airborne Larvotto Resources has discovered gold grading more than 65 grams per tonne at the Hillgrove project in NSW.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.